Advisors Asset Management Inc. increased its stake in shares of CVS Health Corp (NYSE:CVS) by 1.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 202,739 shares of the pharmacy operator’s stock after purchasing an additional 3,545 shares during the quarter. Advisors Asset Management Inc.’s holdings in CVS Health were worth $16,487,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CVS. Fieldpoint Private Securities LLC lifted its holdings in CVS Health by 333.3% in the second quarter. Fieldpoint Private Securities LLC now owns 1,300 shares of the pharmacy operator’s stock valued at $105,000 after buying an additional 1,000 shares during the period. Arcadia Investment Management Corp MI lifted its holdings in CVS Health by 119.6% in the third quarter. Arcadia Investment Management Corp MI now owns 1,333 shares of the pharmacy operator’s stock valued at $108,000 after buying an additional 726 shares during the period. MPS Loria Financial Planners LLC acquired a new position in CVS Health in the second quarter valued at approximately $119,000. Gemmer Asset Management LLC lifted its holdings in CVS Health by 15.3% in the second quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock valued at $121,000 after buying an additional 200 shares during the period. Finally, Captrust Financial Advisors acquired a new position in CVS Health in the second quarter valued at approximately $155,000. 81.69% of the stock is currently owned by institutional investors and hedge funds.

Several brokerages recently weighed in on CVS. Cowen restated an “outperform” rating and issued a $99.00 price objective (up from $81.00) on shares of CVS Health in a report on Thursday. Vetr lowered shares of CVS Health from a “hold” rating to a “sell” rating and set a $76.66 price objective on the stock. in a report on Tuesday. Leerink Swann increased their price objective on shares of CVS Health from $82.00 to $90.00 and gave the company an “outperform” rating in a report on Monday, January 8th. Oppenheimer restated a “buy” rating and issued a $95.00 price objective on shares of CVS Health in a report on Monday, October 9th. Finally, Mizuho set a $90.00 price objective on shares of CVS Health and gave the company a “buy” rating in a report on Tuesday, October 24th. Two analysts have rated the stock with a sell rating, eight have given a hold rating, twelve have given a buy rating and two have given a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $87.25.

In other news, EVP Lisa Bisaccia sold 29,445 shares of the stock in a transaction on Thursday, December 21st. The shares were sold at an average price of $75.00, for a total transaction of $2,208,375.00. Following the completion of the sale, the executive vice president now owns 15,556 shares of the company’s stock, valued at $1,166,700. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.61% of the stock is owned by corporate insiders.

Shares of CVS Health Corp (CVS) opened at $79.86 on Friday. The company has a current ratio of 1.05, a quick ratio of 0.55 and a debt-to-equity ratio of 0.67. CVS Health Corp has a 12-month low of $66.45 and a 12-month high of $84.00. The stock has a market cap of $80,900.00, a price-to-earnings ratio of 16.50, a PEG ratio of 1.25 and a beta of 0.90.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.49 by $0.01. CVS Health had a net margin of 2.77% and a return on equity of 16.96%. The company had revenue of $46.18 billion during the quarter, compared to the consensus estimate of $46.17 billion. During the same quarter in the prior year, the firm earned $1.64 earnings per share. The firm’s revenue was up 3.5% compared to the same quarter last year. research analysts expect that CVS Health Corp will post 5.89 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 2nd. Stockholders of record on Wednesday, January 24th will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.50%. The ex-dividend date is Tuesday, January 23rd. CVS Health’s dividend payout ratio is 41.32%.

TRADEMARK VIOLATION WARNING: This piece was first reported by Daily Political and is owned by of Daily Political. If you are reading this piece on another site, it was illegally copied and reposted in violation of international copyright & trademark legislation. The correct version of this piece can be viewed at https://www.dailypolitical.com/2018/01/20/cvs-health-corp-cvs-shares-bought-by-advisors-asset-management-inc.html.

CVS Health Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.